<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="132788">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01877278</url>
  </required_header>
  <id_info>
    <org_study_id>11262</org_study_id>
    <nct_id>NCT01877278</nct_id>
  </id_info>
  <brief_title>Wearable Pulsed Electromagnetic Fields Device in Knee Osteoarthritis: Double Blinded, Randomized Clinical Trial</brief_title>
  <official_title>Wearable Pulsed Electromagnetic Fields Device in Knee Osteoarthritis Patients: a Double Blinded, Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Messina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Messina</source>
  <oversight_info>
    <authority>Italy: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the efficacy of a wearable device using pulse
      electromagnetic fields on pain intensity reduction, measured by visual analogue score (VAS)
      and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), in patients
      affected by osteoarthritis Secondary aim is the evaluate the effect on knee effusion
      reduction, when present and to evaluate pain intensity changes corrected by pain threshold
      measured by pressure algometry.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">October 2013</completion_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>pain intensity</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>it will be measured through the visual analogue scale (VAS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain threshold</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>it will be evaluated through pressure algometry</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>active</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>emitting group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>non emitting device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wearable pulsed electromagnetic fields</intervention_name>
    <arm_group_label>active</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
    <other_name>actipatch</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  a diagnosis of primary OA of the knee according to the ACR criteria, including
             radiologic evidence of OA

          -  age &gt;40 years

          -  symptomatic disease for at least 6 months prior to enrollment

          -  persistent pain despite receiving the maximum tolerated doses of conventional medical
             therapy, including acetaminophen (4 gm/day) and/or a nonsteroidal antiinflammatory
             drug (NSAID), with persistent pain defined as a minimum mean score of 25 mm on the
             visual analog scales (VAS) for global pain (0-100-mm range for each) daily pain
             during the month prior to study enrollment

          -  ability to attend followup appointments

        Exclusion Criteria:

          -  secondary causes of OA

          -  local or systemic infection

          -  diabetes mellitus

          -  systemic arthritis

          -  allergy to anesthetic agent or contrast material

          -  coagulopathy

          -  anticoagulant therapy

          -  had previous IA steroid injection

          -  avascular necrosis of bone

          -  patients who are on specific OA pharmacological therapy (NSAIDS, opioids)  for more
             than 2 weeks prior enrollment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gianfilippo Bagnato, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>University of Messina</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gianfilippo Bagnato, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Messina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gianfilippo Bagnato, Professor</last_name>
    <phone>00390902212502</phone>
    <email>bagnato@unime.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gianluca Bagnato, MD</last_name>
    <phone>00393288116911</phone>
    <email>gianbagnato@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Reumatologia, Dipartimento di medicina clinica e sperimentale, Universit√† degli studi di Messina, AOU G. Martino</name>
      <address>
        <city>Messina</city>
        <zip>98100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gianfilippo Bagnato, Professor</last_name>
      <phone>00390902212502</phone>
      <email>bagnato@unime.it</email>
    </contact>
    <contact_backup>
      <last_name>Gianluca Bagnato, MD</last_name>
      <phone>00393288116911</phone>
      <email>gianbagnato@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Gianfilippo Bagnato, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Trock DH, Bollet AJ, Dyer RH Jr, Fielding LP, Miner WK, Markoll R. A double-blind trial of the clinical effects of pulsed electromagnetic fields in osteoarthritis. J Rheumatol. 1993 Mar;20(3):456-60.</citation>
    <PMID>8478852</PMID>
  </reference>
  <reference>
    <citation>Thamsborg G, Florescu A, Oturai P, Fallentin E, Tritsaris K, Dissing S. Treatment of knee osteoarthritis with pulsed electromagnetic fields: a randomized, double-blind, placebo-controlled study. Osteoarthritis Cartilage. 2005 Jul;13(7):575-81.</citation>
    <PMID>15979009</PMID>
  </reference>
  <reference>
    <citation>Pipitone N, Scott DL. Magnetic pulse treatment for knee osteoarthritis: a randomised, double-blind, placebo-controlled study. Curr Med Res Opin. 2001;17(3):190-6.</citation>
    <PMID>11900312</PMID>
  </reference>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 17, 2013</lastchanged_date>
  <firstreceived_date>June 11, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Messina</investigator_affiliation>
    <investigator_full_name>Gianfilippo Bagnato</investigator_full_name>
    <investigator_title>Professore ordinario</investigator_title>
  </responsible_party>
  <keyword>Osteoarthritis</keyword>
  <keyword>Pulsed electromagnetic fields</keyword>
  <keyword>Device</keyword>
  <keyword>Pain</keyword>
  <keyword>Pressure algometry</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
